The Food and Drugs Authority (FDA) has given approval for the Pfizer COVID-19 vaccine to be administered to children between 15 and 17 years.
The Pfizer COVID-19 vaccine has been authorised for children ages 15 and up, widening the Ghana population that will be protected against the virus and bolstering chances for a safe return to full-time school after Christmas and New Year festivities.
The Food and Drugs Authority (FDA) gave the approval for the Pfizer COVID-19 vaccine to be administered to children between 15 and 17 years.
Until the approval on Monday, the national vaccination plan only captured people 18 years and above.
The director-general of the Ghana Health Service (GHS), Dr Patrick Kuma-Aboagye, disclosed this to Graphic Online and said “this is a very important news for us, because the most active group for us are the young ones in that age.”
Reduction in transmission
Vaccinating that group, he said, will help reduce school outbreaks especially for those in school and also help reduce transmission to adults.
He added that it will help Ghana to achieve a proper herd immunity.
Currently data shared by the GHS as of 21 October indicated that Ghana had taken delivery of 1,330,290 doses of the Pfizer vaccine, however, Dr Kuma-Aboagye said the country was expecting more of the Pfizer vaccine soon.